Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hepatitis01:25

Hepatitis

6
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
6
Viruses with RNA Genomes01:29

Viruses with RNA Genomes

1.2K
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
1.2K
Retrovirus Life Cycles01:10

Retrovirus Life Cycles

50.3K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
50.3K
B Cell Activation and Differentiation01:24

B Cell Activation and Differentiation

17.8K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
17.8K
Bacterial Protein Maturation01:26

Bacterial Protein Maturation

674
Bacterial protein maturation is a tightly regulated process that ensures newly synthesized polypeptides achieve correct functional conformations. This maturation involves a series of modifications, folding events, and quality control steps, often assisted by specialized chaperone proteins.N-Terminal ModificationsThe maturation of bacterial polypeptides begins cotranslationally as the polypeptide exits the ribosome. The first amino acid, N-formylmethionine (fMet), is typically modified at the...
674

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatiotemporal distribution of SARS-CoV-2 vaccines and vaccine-related proteins in mice and humans.

Scientific reports·2026
Same author

Targeting a tolerogenic HLA-G genotype to tackle immune evasion and adaptive resistance in HBV-driven HCC.

JHEP reports : innovation in hepatology·2026
Same author

High hepatitis E virus prevalence in pig slurry samples from the north-western region of Germany.

One health (Amsterdam, Netherlands)·2026
Same author

Prevalence and risk factors of viral hepatitis and HIV among people experiencing homelessness in Germany based on a nationwide study.

Scientific reports·2025
Same author

Targeting HBV with RNA interference: Paths to cure.

Science translational medicine·2025
Same author

Classification of the LC4 Primarily-like Cell Line-Recapitulating a CDK4 Overexpressing Immune Evasive HIV-HCV-Induced HCC.

Viruses·2025

Related Experiment Video

Updated: Mar 19, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

14.1K

A Slow Maturation Process Renders Hepatitis B Virus Infectious.

Stefan Seitz1, Caroline Iancu1, Tassilo Volz2

  • 1Department of Infectious Diseases, Molecular Virology, Heidelberg University, Im Neuenheimer Feld 345, 69120 Heidelberg, Germany.

Cell Host & Microbe
|June 21, 2016
PubMed
Summary
This summary is machine-generated.

Hepatitis B virus (HBV) particles mature from an inactive, non-binding form to an infectious, binding form. This maturation switch helps HBV avoid non-productive attachment outside the liver, ensuring efficient infection.

More Related Videos

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.8K
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

8.0K

Related Experiment Videos

Last Updated: Mar 19, 2026

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
09:35

Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle

Published on: February 1, 2017

14.1K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.8K
Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells
09:02

Modeling Hepatitis B Virus Infection in Non-Hepatic 293T-NE-3NRs Cells

Published on: June 5, 2020

8.0K

Area of Science:

  • Virology
  • Cell Biology
  • Hepatology

Background:

  • Hepatitis B virus (HBV) infection is primarily restricted to hepatocytes in the liver.
  • HBV virions typically attach to liver cells via interactions between the PreS envelope protein and heparan sulfate proteoglycans (HSPGs).
  • The ubiquitous presence of HSPGs on various cell types suggests HBV utilizes mechanisms to prevent extrahepatic attachment.

Purpose of the Study:

  • To investigate the mechanisms by which HBV achieves liver-specific infection.
  • To elucidate the dynamic changes in HBV particle structure and function during maturation.
  • To understand how HBV topology influences its infectivity and tissue tropism.

Main Methods:

  • Characterization of HBV particle release and maturation states (N-type vs. B-type).
  • Analysis of PreS protein translocation and its role in HSPG binding.
  • In vivo infection studies using mice with human liver xenografts to compare N-type and B-type particle infectivity.

Main Results:

  • HBV particles are released in an inactive, HSPG-non-binding (N-type) form with hidden PreS domains.
  • N-type particles mature into infectious, HSPG-binding (B-type) particles through spontaneous PreS translocation to the surface.
  • N-type particles are superior in establishing infection in vivo, while mature B-type virions show impaired infectivity and accumulate in extrahepatic tissues.

Conclusions:

  • HBV employs a dynamic topology switch, converting inactive N-type particles to infectious B-type particles.
  • This maturation process likely serves to prevent non-productive viral docking at extrahepatic sites.
  • The findings reveal a novel mechanism for HBV tissue tropism and infection control.